Note | GRM1 encodes five alternative splice variants (1a, 1b, 1c, 1d, and 1e) (Zhu et al., 1999). All five variants contain the same N-terminal, but differ in the amino acid composition of their C-terminal domains due to the alternative splicings (DiRaddo et al., 2013). |
| |
|  |
| |
| Figure 2. There are five human mGluR1 isoforms. The black boxes represent the seven-transmembrane domains of mGluR1. Alternative splicing of mGluR1 mRNA produces five mGluR1 isoforms each with a unique C-termini, which is highlighted by the different colors. The shortest isoform, mGluR1e, is truncated before the seven-transmembrane domains, which results in the expression of only the amino terminal fragment (Costantino and Pellicciari, 1996). Adapted from Hermans and Challiss, 2001. |
| |
Description | mGluR1 is an 1194 amino acid seven-transmembrane domain G-protein coupled receptor normally expressed in neuronal and glial cells in the brain (Stephan et al., 1996; Hermans and Challiss, 2001). Its natural ligand is the excitatory neurotransmitter, L-glutamate. Structurally, mGluR1 has various domains that are necessary for its functions. The N-terminus forms two large extracellular lobes separated by a cavity where the ligand glutamate binds to and is referred to as the amino terminal domain (ATD) or "Venus Fly Trap" (O'Hara et al., 1993; Beqollari and Kammermeier, 2010). ATD is separated from the trans-membrane region of mGluR1 by a 70 amino acid cysteine rich domain (CRD), which is essential for dimerization, and activation of the receptor (Huang et al., 2011). The seven alpha-helical transmembrane domains (TMD) precede the cysteine rich region. Following the TMD is the carboxyl terminus of mGluR1, also known as the intracellular cytoplasmic tail domain (CTD). CTD is involved in modulating G-protein coupling and selectivity (Pin et al., 2003; Seebahn et al., 2013). The CTD is also the region subjected to alternative splicings, regulated by phosphorylation, and modulatory protein-protein interactions (Niswender and Conn, 2010). The CRD is consisted of three beta-pleated sheets and nine cysteine residues. CRD plays a key role in facilitating the allosteric coupling between the ATD and the TMD regions during ligand binding and receptor activation (Niswender and Conn, 2010). Upon activation of mGluR1 by glutamate, the signal induced is transmitted from the ATD through the CRDs, by way of a disulfide bridge formed between the 9th cysteine of the CRD and a cysteine residue in lobe 2 of the ATD (Rondard et al., 2006; Muto et al., 2007). As a result, a conformational change takes place that brings the C-terminal regions of the CRDs closer to one another and elicits cysteine-cysteine interaction in the e2 loop of the TMD (Muto et al., 2007). This conformational change produces a shift in the TMD to induce G-protein activation (El Moustaine et al., 2012). |
Expression | mGluR1 is normally expressed in the central nervous system and is activated by its natural ligand, L-glutamate (Teh and Chen, 2012a). Upon activation, mGluR1 couples to Gα/q11 proteins to induce phosphatidylinositol (4,5)-biphosphate (PIP2) hydrolysis leading to the formation of two-second messengers, inositol 1,4,5-triphosphate (IP3) and diacyglycerol (DAG) (Conn and Pin, 1997; Hermans and Challiss, 2001). These second messengers stimulate intracellular calcium release from the endoplasmic reticulum (ER) stores and activate protein kinase C (PKC), resulting in the stimulation of G-protein-independent signal transduction pathways (Hermans and Challiss, 2001; Goudet et al., 2009). Such pathways include the mitogen activated protein kinase pathway (MAPK) and the phosphatidylinositol-3-kinase (PI3K)/AKT pathway (Marín, et al., 2006; Shin et al., 2010). |
|  |
| |
| Figure 3. Diagram of the proposed signal transduction pathways elicited by stimulated mGluR1. Adapted from Teh and Chen, 2012b. |
| |
Localisation | Cell membrane of neurons. |
Function | mGluR1 activation is involved in mediating neuronal excitability, synaptic plasticity, and feedback inhibition of neurotransmitter release (Speyer et al., 2012). All of which promotes learning and memory formation in the central nervous system (Hermans and Challiss, 2001). |
Venus fly trap domain of mGluR1 functions as a dominant negative against group I mGluR signaling. |
Beqollari D, Kammermeier PJ. |
J Neurophysiol. 2010 Jul;104(1):439-48. doi: 10.1152/jn.00799.2009. Epub 2010 May 12. |
PMID 20463192 |
|
Pharmacology and functions of metabotropic glutamate receptors. |
Conn PJ, Pin JP. |
Annu Rev Pharmacol Toxicol. 1997;37:205-37. (REVIEW) |
PMID 9131252 |
|
Homology modeling of metabotropic glutamate receptors. (mGluRs) structural motifs affecting binding modes and pharmacological profile of mGluR1 agonists and competitive antagonists. |
Costantino G, Pellicciari R. |
J Med Chem. 1996 Sep 27;39(20):3998-4006. |
PMID 8831765 |
|
Two newly identified exons in human GRM1 express a novel splice variant of metabotropic glutamate 1 receptor. |
DiRaddo JO, Pshenichkin S, Gelb T, Wroblewski JT. |
Gene. 2013 May 1;519(2):367-73. doi: 10.1016/j.gene.2013.02.009. Epub 2013 Feb 24. |
PMID 23481697 |
|
Distinct roles of metabotropic glutamate receptor dimerization in agonist activation and G-protein coupling. |
El Moustaine D, Granier S, Doumazane E, Scholler P, Rahmeh R, Bron P, Mouillac B, Baneres JL, Rondard P, Pin JP. |
Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16342-7. doi: 10.1073/pnas.1205838109. Epub 2012 Sep 17. |
PMID 22988116 |
|
Triple-negative breast cancer and the need for new therapeutic targets. |
Engebraaten O, Vollan HK, Borresen-Dale AL. |
Am J Pathol. 2013 Oct;183(4):1064-74. doi: 10.1016/j.ajpath.2013.05.033. Epub 2013 Aug 3. |
PMID 23920327 |
|
Somatic mutations in GRM1 in cancer alter metabotropic glutamate receptor 1 intracellular localization and signaling. |
Esseltine JL, Willard MD, Wulur IH, Lajiness ME, Barber TD, Ferguson SS. |
Mol Pharmacol. 2013 Apr;83(4):770-80. doi: 10.1124/mol.112.081695. Epub 2013 Jan 9. |
PMID 23303475 |
|
Metabotropic receptors for glutamate and GABA in pain. |
Goudet C, Magnaghi V, Landry M, Nagy F, Gereau RW 4th, Pin JP. |
Brain Res Rev. 2009 Apr;60(1):43-56. doi: 10.1016/j.brainresrev.2008.12.007. Epub 2008 Dec 25. (REVIEW) |
PMID 19146876 |
|
Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors. |
Hermans E, Challiss RA. |
Biochem J. 2001 Nov 1;359(Pt 3):465-84. (REVIEW) |
PMID 11672421 |
|
Interdomain movements in metabotropic glutamate receptor activation. |
Huang S, Cao J, Jiang M, Labesse G, Liu J, Pin JP, Rondard P. |
Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15480-5. doi: 10.1073/pnas.1107775108. Epub 2011 Sep 6. |
PMID 21896740 |
|
Diverse somatic mutation patterns and pathway alterations in human cancers. |
Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, Stern HM, Yue P, Haverty PM, Bourgon R, Zheng J, Moorhead M, Chaudhuri S, Tomsho LP, Peters BA, Pujara K, Cordes S, Davis DP, Carlton VE, Yuan W, Li L, Wang W, Eigenbrot C, Kaminker JS, Eberhard DA, Waring P, Schuster SC, Modrusan Z, Zhang Z, Stokoe D, de Sauvage FJ, Faham M, Seshagiri S. |
Nature. 2010 Aug 12;466(7308):869-73. doi: 10.1038/nature09208. Epub 2010 Jul 28. |
PMID 20668451 |
|
Stimulation of oncogenic metabotropic glutamate receptor 1 in melanoma cells activates ERK1/2 via PKCepsilon. |
Marin YE, Namkoong J, Cohen-Solal K, Shin SS, Martino JJ, Oka M, Chen S. |
Cell Signal. 2006 Aug;18(8):1279-86. Epub 2005 Nov 21. |
PMID 16305822 |
|
Structures of the extracellular regions of the group II/III metabotropic glutamate receptors. |
Muto T, Tsuchiya D, Morikawa K, Jingami H. |
Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3759-64. Epub 2007 Feb 26. |
PMID 17360426 |
|
Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma. |
Namkoong J, Shin SS, Lee HJ, Marin YE, Wall BA, Goydos JS, Chen S. |
Cancer Res. 2007 Mar 1;67(5):2298-305. |
PMID 17332361 |
|
Metabotropic glutamate receptors: physiology, pharmacology, and disease. |
Niswender CM, Conn PJ. |
Annu Rev Pharmacol Toxicol. 2010;50:295-322. doi: 10.1146/annurev.pharmtox.011008.145533. (REVIEW) |
PMID 20055706 |
|
The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins. |
O'Hara PJ, Sheppard PO, Thogersen H, Venezia D, Haldeman BA, McGrane V, Houamed KM, Thomsen C, Gilbert TL, Mulvihill ER. |
Neuron. 1993 Jul;11(1):41-52. |
PMID 8338667 |
|
Evolution, structure, and activation mechanism of family 3/C G-protein-coupled receptors. |
Pin JP, Galvez T, Prezeau L. |
Pharmacol Ther. 2003 Jun;98(3):325-54. (REVIEW) |
PMID 12782243 |
|
Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia. |
Pollock PM, Cohen-Solal K, Sood R, Namkoong J, Martino JJ, Koganti A, Zhu H, Robbins C, Makalowska I, Shin SS, Marin Y, Roberts KG, Yudt LM, Chen A, Cheng J, Incao A, Pinkett HW, Graham CL, Dunn K, Crespo-Carbone SM, Mackason KR, Ryan KB, Sinsimer D, Goydos J, Reuhl KR, Eckhaus M, Meltzer PS, Pavan WJ, Trent JM, Chen S. |
Nat Genet. 2003 May;34(1):108-12. |
PMID 12704387 |
|
Coupling of agonist binding to effector domain activation in metabotropic glutamate-like receptors. |
Rondard P, Liu J, Huang S, Malhaire F, Vol C, Pinault A, Labesse G, Pin JP. |
J Biol Chem. 2006 Aug 25;281(34):24653-61. Epub 2006 Jun 20. |
PMID 16787923 |
|
Comment on "The consensus coding sequences of human breast and colorectal cancers". |
Rubin AF, Green P. |
Science. 2007 Sep 14;317(5844):1500. |
PMID 17872429 |
|
Expression, purification, and structural analysis of intracellular C-termini from metabotropic glutamate receptors. |
Seebahn A, Sticht H, Enz R. |
Methods Enzymol. 2013;520:257-79. doi: 10.1016/B978-0-12-391861-1.00012-5. |
PMID 23332704 |
|
Oncogenic activities of metabotropic glutamate receptor 1 (Grm1) in melanocyte transformation. |
Shin SS, Namkoong J, Wall BA, Gleason R, Lee HJ, Chen S. |
Pigment Cell Melanoma Res. 2008 Jun;21(3):368-78. doi: 10.1111/j.1755-148X.2008.00452.x. Epub 2008 Apr 23. |
PMID 18435704 |
|
AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1). |
Shin SS, Wall BA, Goydos JS, Chen S. |
Pigment Cell Melanoma Res. 2010 Feb;23(1):103-11. doi: 10.1111/j.1755-148X.2009.00648.x. Epub 2009 Oct 20. |
PMID 19843246 |
|
The consensus coding sequences of human breast and colorectal cancers. |
Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE. |
Science. 2006 Oct 13;314(5797):268-74. Epub 2006 Sep 7. |
PMID 16959974 |
|
Glutamate signalling in non-neuronal tissues. |
Skerry TM, Genever PG. |
Trends Pharmacol Sci. 2001 Apr;22(4):174-81. (REVIEW) |
PMID 11282417 |
|
Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer. |
Speyer CL, Smith JS, Banda M, DeVries JA, Mekani T, Gorski DH. |
Breast Cancer Res Treat. 2012 Apr;132(2):565-73. doi: 10.1007/s10549-011-1624-x. Epub 2011 Jun 17. |
PMID 21681448 |
|
Human metabotropic glutamate receptor 1: mRNA distribution, chromosome localization and functional expression of two splice variants. |
Stephan D, Bon C, Holzwarth JA, Galvan M, Pruss RM. |
Neuropharmacology. 1996;35(12):1649-60. |
PMID 9076744 |
|
mGlu Receptors and Cancerous Growth. |
Teh J, Chen S. |
Wiley Interdiscip Rev Membr Transp Signal. 2012b Mar;1(2):211-220. Epub 2011 Oct 25. |
PMID 22662310 |
|
Glutamatergic signaling in cellular transformation. |
Teh JL, Chen S. |
Pigment Cell Melanoma Res. 2012a May;25(3):331-42. doi: 10.1111/j.1755-148X.2012.00983.x. Epub 2012 Feb 20. (REVIEW) |
PMID 22273393 |
|
Cloning of novel splice variants of mouse mGluR1. |
Zhu H, Ryan K, Chen S. |
Brain Res Mol Brain Res. 1999 Nov 10;73(1-2):93-103. |
PMID 10581402 |
|